Login / Signup

Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.

Ramzi G SalloumJeffrey R BishopAmanda L ElchynskiD Max SmithElizabeth RoweKathryn V BlakeNita A LimdiChristina L AquilanteJill BatesAmber L BeitelsheesAmber CiprianiBenjamin Q DuongPhilip E EmpeyChristine M FormeaJ Kevin HicksPawel MrozDavid OslinAmy L PasternakNatasha PetryLaura B RamseyAllyson SchlichteSandra M SwainKristen M WardKristin WiisanenTodd C SkaarSara L Van DriestLarisa H CavallariSony Tuteja
Published in: Implementation science communications (2022)
This study demonstrates the feasibility of using choice experiments to systematically evaluate the relative importance of implementation determinants from the perspective of implementing organizations. BWS findings can inform other organizations interested in implementing PGx testing for mental health. Further, this study demonstrates the application of BWS to PGx, the findings of which may be used by other organizations to inform implementation of PGx testing for mental health disorders.
Keyphrases
  • mental health
  • quality improvement
  • primary care
  • healthcare
  • major depressive disorder
  • stem cells
  • bipolar disorder
  • cell therapy